Femara Beligas

£144.00

Femara Beligas is a pharmaceutical-grade aromatase inhibitor containing letrozole for laboratory research applications studying estrogen biosynthesis pathways.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Femara Beligas
Femara Beligas
£144.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Compound Profile: Femara Beligas

Femara Beligas is a pharmaceutical-grade aromatase inhibitor containing letrozole as the active compound for advanced laboratory research applications. Letrozole belongs to the third-generation class of non-steroidal aromatase inhibitors and represents a highly potent tool for investigating estrogen biosynthesis pathways in controlled research environments. This Beligas formulation provides researchers at Stroid UK Shop with a reliable reference compound for studying the mechanisms of estrogen suppression and exploring hormonal regulatory systems in experimental models.

Laboratory Applications

Research scientists utilise Femara Beligas to investigate the role of aromatase enzyme inhibition in various biological processes. Studies examine how letrozole blocks the conversion of androgens to estrogens by competitively inhibiting the cytochrome P450 enzyme complex responsible for aromatisation. Laboratory investigations focus on understanding estrogen-dependent cellular mechanisms, hormone receptor interactions, and the downstream effects of estrogen depletion in experimental systems. Researchers studying aromatase inhibitor compounds particularly value this pharmaceutical-grade preparation for its consistency and purity in experimental protocols. Comparative studies with selective androgen receptor modulators and research peptides enhance understanding of complex hormonal pathway interactions.

Technical Specifications

Femara Beligas Research Compound Specifications
Parameter Specification
Active Compound Letrozole
CAS Number 112809-51-5
Molecular Formula C₁₇H₁₁N₅
Molecular Weight 285.30 g/mol
Storage Requirements Room temperature, dry environment
Manufacturer Beligas Pharmaceuticals

Research Compliance

Femara Beligas is supplied exclusively for in-vitro laboratory research purposes and is not intended for human consumption or therapeutic use. This aromatase inhibitor research compound is designed for qualified researchers investigating estrogen biosynthesis mechanisms, hormonal pathway modulation, and related biochemical processes in controlled laboratory settings. All research applications must comply with institutional guidelines and local regulations governing the use of research chemicals.

Related